Company intelligence / Profile preview
WntGen
Palo Alto, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
WntGen is a biotechnology company focused on developing novel therapeutics that modulate the Wnt signaling pathway to treat a variety of diseases, including those requiring tissue regeneration and oncology. Founded by world-renowned experts in Wnt biology, the company leverages deep mechanistic insights to create targeted therapies. Their approach focuses on precision modulation of Wnt-Frizzled interactions to promote healing or inhibit tumor growth. WntGen's pipeline is currently in the pre-clinical stage, targeting indications in bone health and regenerative medicine. The company aims to translate decades of foundational research into transformative medicines for patients with high unmet needs.
- Therapeutic areas
- OncologyRheumatologyOtherGastroenterology
- Modalities
- BiologicRecombinant proteinSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on WntGen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WntGen.